US STOCKS-Futures fall as Trump, Hong Kong weaken mood

(For a live blog on the U.S. stock market, click LIVE/ or
type LIVE/ in a news window.)
* Futures down: Dow 0.41%, S&P 0.37%, Nasdaq 0.43%

By Arjun Panchadar
Nov 11 (Reuters) - U.S. stock index futures fell on Monday
as President Donald Trump's comments dampened expectations
around a U.S.-China trade deal, while escalating violence in
Hong Kong added to investor worries.
Hopes of a "phase one" deal to end the damaging 16-month
trade war and largely upbeat corporate earnings have sparked a
rally that helped the three major stock indexes close at record
highs on Friday.
But Trump said on Saturday that the United States would only
make a deal if it was the "right deal" for America, adding that
the talks had moved more slowly than he would have liked.
Trade-sensitive stocks Caterpillar Inc CAT.N Advanced
Micro Devices Inc AMD.O , Micron Technology MU.O and Intel
Corp INTC.O shed between 0.8% and 1.3% in premarket trading.
With the third-quarter earnings season drawing to a close,
attention will now be on economic data, as well as comments from
Federal Reserve Chair Jerome Powell later this week.
At 7:34 a.m. ET, Dow e-minis 1YMcv1 were down 113 points,
or 0.41%. S&P 500 e-minis EScv1 were down 11.5 points, or
0.37% and Nasdaq 100 e-minis NQcv1 were down 35.5 points, or
0.43%.
Continuing violence in Hong Kong also hit sentiment after
police shot and wounded a protester in the 24th straight week of
pro-democracy protests in the Chinese-ruled territory.
Qualcomm Inc QCOM.O fell 1.8% after Morgan Stanley
downgraded the chipmaker to "equal-weight" from "overweight".
Cisco Systems Inc CSCO.O dropped 1.3% as Piper Jaffray cut
its rating on the networking equipment maker to "neutral" from
"overweight".
SunPower Corp SPWR.O gained 3.8% after the solar cell and
panel maker said it would split into two separate
publicly-traded companies.
Lipocine Inc LPCN.O slumped 67% after the U.S. Food and
Drug Administration declined to approve its oral drug to treat a
condition that results in lower production of sex hormone.